METTL3 and esophageal squamous cell carcinoma: Here, we concluded that METTL3 as an oncogene, promoted both proliferation and metastasis of ESCC by COL12A1/RAF/MEK/ERK/MAPK signaling pathway, suggesting that METTL3 may be a candidate prognostic biomarker for ESCC.